— College of Public Health — Departments — Biostatistics — Faculty & Staff — James R. Anderson, PhD

James R. Anderson, PhD

Adjunct Professor, UNMC Department of Biostatistics

Send Email

Phone: 402-559-6825
Fax: 402-559-7259

James R. Anderson is an adjunct professor in the Department of Biostatistics in the UNMC College of Public Health. He previously served for eight years as a distinguished scientist for Merck and Co. following his roles as a biostatistics professor in the UNMC College of Public Health, and as professor and chair of the Department of Preventative and Societal Medicine in the UNMC College of Medicine.

He also has served as a visiting professor in the Department of Biostatistics & Medical Informatics at the University of Wisconsin-Madison and held faculty roles in the Harvard School of Public Health Department of Biostatistics and the University of Southern California Department of Community & Family Medicine.

Education

PhD Biostatistics, University of Washington, 1979
BA Mathematics, SUNY Buffalo, 1973

Research Interests

Dr. Anderson's research interests include the design, conduct and analysis of clinical trials, especially cancer clinical trials, time.-to-event analyses and medical ethics

Selected Publications

Anderson JR, Bernstein L, Pike MC. Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis. Biometrics. 38(2): 407-16. 1982.
Anderson JR, Wilson JF, Jenkin DT, Meadows AT, Kersey J, Chilcote RR, Coccia P, Exelby P, Kushner J, Siegel S, Hammond D. Childhood non-Hodgkin’s lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2- L2). The New England Journal of Medicine. 308(10): 559-65. 1983.
Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 1(11): 710-9. 1983.
Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA. Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. The New England Journal of Medicine. 327(21): 1478-84. 1992.
Anderson JR, Jameton A, Reitemeier PJ, Prentice E. The case of two devices: disclosure to subjects following Phase IV (post-marketing) research. IRB. 17(3): 6-9. 1996.